Literature DB >> 17157756

A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer.

Jennifer Philip1, Michelle Gold, Alvin Milner, Juliana Di Iulio, Belinda Miller, Odette Spruyt.   

Abstract

Dyspnea is a common symptom in palliative care. Despite this, there is uncertainty regarding the role of oxygen to treat the symptom in patients with advanced illness. This randomized, double-blind, crossover trial examined the effect of oxygen versus air on the relief of dyspnea in patients with advanced cancer. Following the blinded administration of air and oxygen via nasal prongs, 51 patients rated dyspnea and indicated preferences for the blinded treatments. On average, patients improved symptomatically with both air and oxygen, and there were no significant differences between the treatments. The subgroup of 17 hypoxic patients overall did not demonstrate a significant difference between air and oxygen, despite having improved oxygen saturations when administered oxygen. Hypoxia was corrected in 13 of 17 patients using the treatment dose of 4 L/min of oxygen. The experience of dyspnea is a complex, multifactorial phenomenon, with oxygen tension not correlating with the subjective experience. The administration of either air or oxygen via nasal prongs on average confers improvement of the symptom.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157756     DOI: 10.1016/j.jpainsymman.2006.06.009

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  12 in total

Review 1.  Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature.

Authors:  Matthäus Strieder; Martin Pecherstorfer; Gudrun Kreye
Journal:  Wien Med Wochenschr       Date:  2017-09-18

2.  Patients' experience of oxygen therapy and dyspnea: a qualitative study in home palliative care.

Authors:  Darin Jaturapatporn; Erica Moran; Chris Obwanga; Amna Husain
Journal:  Support Care Cancer       Date:  2010-03-21       Impact factor: 3.603

3.  Humidified high-flow nasal oxygen utilization in patients with cancer at Memorial Sloan-Kettering Cancer Center.

Authors:  Andrew S Epstein; Sidonie K Hartridge-Lambert; Judson S Ramaker; Louis P Voigt; Carol S Portlock
Journal:  J Palliat Med       Date:  2011-05-20       Impact factor: 2.947

4.  Singapore First Aid Guidelines 2021.

Authors:  Faraz Zarisfi; Jen Heng Pek; Janice Hui Hong Oh; Jun Hao Loke; Swee Han Lim
Journal:  Singapore Med J       Date:  2021-08       Impact factor: 1.858

5.  Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study.

Authors:  Katri Elina Clemens; Ines Quednau; Eberhard Klaschik
Journal:  Support Care Cancer       Date:  2008-08-22       Impact factor: 3.603

Review 6.  The symptomatic relief of dyspnea.

Authors:  Giovanni Elia; Jay Thomas
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

7.  Hand-held Fan Airflow Stimulation Relieves Dyspnea in Lung Cancer Patients.

Authors:  Ni Luh Putu Dewi Puspawati; Ratna Sitorus; Tuti Herawati
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Apr-Jun

Review 8.  Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis.

Authors:  H E Uronis; D C Currow; D C McCrory; G P Samsa; A P Abernethy
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

Review 9.  Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosis.

Authors:  Maria A Trawinska; Ruwani D Rupesinghe; Simon P Hart
Journal:  Ther Clin Risk Manag       Date:  2016-04-08       Impact factor: 2.423

10.  When should I be considering home oxygen for my patients?

Authors:  Jay Suntharalingam; Sabrine Hippolyte; Vikki Knowles; Daryl Freeman; Irem Patel; Maxine Hardinge
Journal:  NPJ Prim Care Respir Med       Date:  2016-01-07       Impact factor: 2.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.